T Scientific Becomes Second Largest Shareholder of TMD Lab, an Advanced New Material Implantable Medical Device Company

[Asia Economy Reporter Hyunseok Yoo] T Scientific is strengthening its partnership by acquiring additional shares in TMD Lab, a research and development company specializing in implantable shape-memory polymer medical devices.

T Scientific announced on the 20th that following its acquisition of a 3.87% stake in TMD Lab last May, it has increased its shareholding to 12.54%, becoming the second-largest shareholder. Including related parties, it now holds a total of 20.68% of TMD Lab's shares.

T Scientific plans to promote a cooperative system and joint research and development for the commercialization of products developed by TMD Lab, and to strengthen business cooperation with TMD Lab in establishing sales organizations in major advanced countries such as the United States and Europe.

TMD Lab has completed all preclinical trials for the implantable medical device "Nugan Stent," which uses shape-memory polymers, and is preparing for approval from the Ministry of Food and Drug Safety. It is also developing vascular external wall supports, biliary stents, and plastic surgery aids. Additionally, to collaborate with global major companies according to the development stage of each product, it plans to establish a U.S. branch early next year.

Furthermore, TMD Lab is accelerating efforts toward technology-specialized listing by advancing various pipelines and commercialization through research and development.

This content was produced with the assistance of AI translation services.